RESPIRATORY FUNCTION DISORDERS IN THE EARLY CONVALESCENT PERIOD IN PEOPLE AFTER A NEW CORONAVIRUS INFECTION

The aim of the work is to study respiratory function disorders in the early convalescent period in people after a new coronavirus infection using clinical, laboratory and functional research methods.
Material and methods. 60 patients aged 23 to 79 years old (average age 62.5±6.2 years old) with a new coronavirus infection in the early convalescent period (up to 2 months after discharge) were examined.
Results. Statistically significant differences in subgroups were found in all the studied indicators. The obtained statistical data of pulse oximetry may indicate the beginning of the development of respiratory failure in patients with severe coronavirus infection caused by both concomitant pathologies (chronic obstructive pulmonary disease) and may indicate the initial stage of the formation of pulmonary fibrosis.
Conclusion. As a result of the performed clinical, laboratory and functional studies in the observation group and analysis of the data obtained, a statistically significant correlation was established between the severity of the new coronavirus infection, the patient's comorbidity, age, adherence to therapy in the acute period of the disease and the functional state of the respiratory system in the early convalescent period.

1. Chuchalin A. G. Pulmonary fibrosis in patients with COVID-19. Therapeutic archive. 2022; 94(11):1333-1339. (in Russ)

2. Babiker A., [et al.] SARS-CoV-2 testing. Am. J. Clin. Pathol. 2020; 153(6):706–708. (in Engl)

3. Ashour H.M., [et al.] Insights into the recent 2019 novel coronavirus (SARS-CoV-2) in light of past human coronavirus outbreaks. Pathogens. 2020; 9(3):186 (in Engl)

4. Holmes E.C., Zhang Y.Z. Novel 2019 coronavirus genome. 2020. [Electronic resouce] URL: http://virological.org/t/novel-2019- coronavirus-genome/319 (in Engl)

5. Yi Y., [et al.] COVID-19: what has been learned and to be learned about the novel coronavirus disease. Int. J. Biol. Sci. 2020; 16(10):1753-1766. (in Engl)

6. Bontsevich, R.A., Zaeva A.A., Gavrilov P.V. The case of managing a patient with prolonged persistence of postcovid syndrome and the presence of gross interstitial changes in the lungs. Actual problems of medicine. 2023; 46(1):23-37. DOI 10.52575/2687-0940-2023-46-1-23-37. (in Russ)

7. Al-Hazmi A. Challenges presented by MERS corona virus, and SARS corona virus to global health. Saudi J. Biol. Sci. 2016; 23(4):507– 511. (in Engl)

8. Buryachkovskaya L. I., Melkumyants A.M., Lomakin N. V. [et al.] Damage to the vascular endothelium and erythrocytes in patients with COVID-19. Consilium Medicum. 2021; 23(6):469-476. DOI 10.26442/20751753.2021.6.200939. (in Russ)

9. Wu F., [et al.] A new coronavirus associated with human respiratory disease in China. Nature. 2020; 579(7798):265–269. (in Engl)

10. Hopkins Universidade John, Baltimore E. Coronavirus COVID-19 global cases by the center for systems science and engineering (CSSE) 2020. https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6 (in Engl)

11. Wu Y, Goplen N, Sun J. Aging and respiratory viral infection: from acute morbidity to chronic sequelae. Cell Biosci. 2021;11:112. (in Engl)

12. Soboleva, N.A. Short-term and long-term effects of coronavirus infection on the body (review) / N.A. Soboleva // Complex studies of childhood. – 2022. – Vol. 4, No. 2. – pp. 134-141. – DOI 10.33910/2687-0223-2022-4-2-134-141. (in Russ)

13. Matthay M.A., [et al.] Acute respiratory distress syndrome. Nat Rev Dis Primers. 2019; 5(1):18. (in Engl)

14. Ashbaugh D.G., [et al.] Acute respiratory distress in adults. Lancet. 1967;2(7511):319–323. (in Engl)

15. Force A.D.T., [et al.] Acute respiratory distress syndrome: the Berlin Definition. J. Am. Med. Assoc. 2012; 307(23):2526–2533. (in Engl)

16. Bellani G., [et al.] Epidemiology, patterns of Care, and mortality for patients with acute respiratory distress syndrome in intensive Care units in 50 countries. J. Am. Med. Assoc. 2016; 315(8):788–800. (in Engl)

17. Meyer N.J., Calfee C.S. Novel translational approaches to the search for precision therapies for acute respiratory distress syndrome. Lancet Respir Med. 2017; 5(6):512–523. (in Engl)

18. Duan J, Wu Y, Liu C, Yang C, Yang L. Deleterious effects of viral pneumonia on cardiovascular system. Eur Heart J. 2020; 41(19):1833–1838. doi: 10.1093/eurheartj/ehaa325. (in Engl)

19. Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, Easton A, Kneen R, Defres S, Sejvar J, Solomon T. Neurological associations of COVID-19. Lancet Neurol. 2020; 19(9):767–783. (in Engl)